Health Market News: Acetaminophen Prop 65 Report Posted; Loperamide Brands' Smaller Packaging
Brand-name loperamide OTCs will be packaged in single doses with no more than 48 mg per container; and California posts acetaminophen hazard identification for Prop 65 consideration.
You may also be interested in...
FDA approval for Perrigo's ANDA for two loperamide products listed as tablets follows CBE label changes Johnson & Johnson and BionPharma made for their branded OTCs containing the ingredient in 2019.
Babies with cord blood biomarkers of acetaminophen on higher end of a scale are at three times risk of attention-deficit/hyperactivity disorder and almost four times at risk of autism spectrum disorder than babies with biomarkers on lower end, according to a JAMA study with 996 mother-infant pairs.
Instruction in Appropriations Committee report on FY 2020 spending bill garners support from some stakeholders while others say setting a safe level of CBD's use in non-drug products should come first. Senate appropriators endorses FDA policy that regulations allowing sales of CBD non-drug products "not discourage the development of new drugs."